Evidence map›Paper›PMID 28097231›Full record

Trial reportJCI insight2017

Protein disulfide isomerase inhibition blocks thrombin generation in humans by interfering with platelet factor V activation.

Jack D Stopa, Donna Neuberg, Maneka Puligandla, Bruce Furie, Robert Flaumenhaft, Jeffrey I Zwicker

Open access · goldAbstract readClinical TrialComparative Study
In one paragraph

Trial report in JCI insight, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it, 113 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Molecular mechanisms of protein disulfide isomerase antagonism by punicalagin.Biochemical and biophysical research communications · 2026
    Article
  4. Article
  5. Article
  6. bioRxiv : the preprint server for biology · 2026
    Article
  7. Review
  8. Assays of Thiol Isomerase Activity.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Platelets welcome a new protein disulfide isomerase family member.Journal of thrombosis and haemostasis : JTH · 2025
    Article
  15. Biotransformation of Xanthohumol by Entomopathogenic Filamentous Fungi.International journal of molecular sciences · 2024
    Article
  16. Article
  17. Article
  18. Research advances ofFrontiers in immunology · 2024
    Review
  19. Review
  20. Targeting thiol isomerase activity with zafirlukast to treat ovarian cancer from the bench to clinic.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023
    Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jack D StopaDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School.
Donna NeubergDepartment of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
Maneka PuligandlaDepartment of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
Bruce FurieDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School.
Robert FlaumenhaftDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School.
Jeffrey I ZwickerDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School.
Dana-Farber Cancer Institute · US

Funding

Translational Research Skills DevelopmentU54HL112302 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FURIE, BRUCE · 2012 to 2016
$11.1M
Thiol Isomerases in Hemostasis and ThrombosisR35HL135775 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FLAUMENHAFT, ROBERT C · 2017 to 2023
$5.5M
Targeting the Endothelium in SepsisR01HL125275 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FLAUMENHAFT, ROBERT C, PARIKH, SAMIR M · 2014 to 2018
$4.2M
Vascular Thiol Isomerases in ThrombosisR01HL136394 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ITALIANO, JOSEPH E, ZWICKER, JEFFREY · 2017 to 2020
$3.3M
Platelet granule exocytosis and thrombus formationR01HL112809 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FLAUMENHAFT, ROBERT C · 2013 to 2016
$1.8M
NHLBI NIH HHS R01 HL112809NHLBI NIH HHS R01 HL125275NHLBI NIH HHS R01 HL136394NHLBI NIH HHS R35 HL135775NHLBI NIH HHS U54 HL112302
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Administration, OralAnimalsAntiphospholipid SyndromeBlood Coagulation FactorsHumansModels, AnimalProtein Disulfide-IsomerasesQuercetinThrombinBlood Coagulation Factorsisoquercitrinplatelet factor VProtein Disulfide-IsomerasesQuercetinThrombin

Identifiers

PMID28097231
PMCPMC5214567
OpenAlexW2572468017

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.